Markets
Alex Karp Palantir CEO
Palantir CEO Alex Karp and Booz Allen Hamilton CEO Horacio Rozanski (Andrew Harnik/Getty Images)
Indexy is Sexy

Palantir tops S&P 500, aims for Nasdaq 100

That would mean it would be added to the heavily traded QQQ, one of the largest ETFs in the world with over $300 billion in AUM.

Matt Phillips

Another good day for data, surveillance, and defense contracting giant Palantir Technologies on Friday, as the shares continue their recent tear to become top performer in the S&P 500 for the year in early trading, overtaking Vistra after having passed Nvidia earlier this month.

The company announced today that it was moving its stock listing — the ticker will remain PLTR — from the NYSE to the Nasdaq on November 26, noting that “upon transferring, Palantir anticipates meeting the eligibility requirements of the Nasdaq-100 Index.”

Company management seems to have come to appreciate the benefits of index inclusion this year. It matters a lot, as once you’re in the index, the myriad of so called “passive” investing products — ETFs, mutual funds, etc. — that merely mirror the official benchmark simply have to buy the stock, regardless of what they think of its prospects or governance. What’s more, they can’t sell it, unless it’s delisted or thrown out of the index.

It was only included in September in the S&P 500, which has more than $16 trillion in investment products like ETFs, mutual funds, or portfolios run by institutional investors such as pension funds pegged to it. (That doesn’t include the untold amount of money that’s unofficially mirroring the index by so-called closet indexers.)

Inclusion in the Nasdaq 100 could open up another — though admittedly smaller — group of performance-agnostic buyers, as it is the basis for several giant ETFs like Invesco QQQ Trust, which has more than $300 billion in assets under management. But that’s another layer of steady demand from Wall Street institutions that can balance out the somewhat excitable retail shareholder base that the company has built.

More Markets

See all Markets
markets

Spectrum owner Charter Communications is on pace for its worst day ever as broadband numbers and Q1 results disappoint

Cable and broadband company Charter Communications is on pace for its worst-ever trading day on Friday, as investors dump the stock following its Q1 results and forward guidance.

Charter, which owns Spectrum, reported adjusted earnings of $9.17 per share, below Wall Street estimates of $9.96 per share from analysts polled by FactSet. On the company’s earnings call, CFO Jessica Fischer appeared to lower its guidance for full-year revenue per user.

“It’ll be close either way in terms of whether we end up with net growth,” Fischer said.

The company lost 120,000 internet subscribers in the quarter, deeper than the expected 94,800 and double its loss from the same period last year. That news comes one day after Comcast’s earnings provided a bit of optimism for broadband as a category: the company reported Q1 losses of 65,000, significantly improving from 183,000 losses in the same quarter last year. Comcast is down more than 10%, on pace for its worst day since January 2025.

markets

Nvidia poised to snap longest run without a record close since the AI boom began

The stock price of the company responsible for the brains of the AI boom is finally showing some brawn again.

Nvidia, the world’s most valuable company, is poised to close at a record high for the first time since October 29, 2025, on Friday (if it ends above $207.04).

The AI chip trade is on fire, with the Philadelphia Semiconductor Index slated to deliver its 18th consecutive gain as Intel’s robust results and outlook juice the entire ecosystem. Hyperscalers report earnings next week, and their capex guidance can be thought of as the earnings guidance for Nvidia and other AI suppliers for the quarters to come.

This would end Nvidia’s longest stretch without a record close since the unofficial start of the AI boom (when the chip designer delivered blowout quarterly results in May 2023).

(Sorry if I jinx this!)

markets

Lilly slips after prescriptions for its weight-loss pill come in below expectations in second week

Eli Lilly fell on Friday after prescription data for its new weight-loss pill, Foundayo, showed that it’s having a significantly slower rollout than its top competitor.

The pill was prescribed about 3,700 times in its second week, according to IQVIA data cited by Deutsche Bank analysts, compared to the roughly 8,000 they were expecting. Novo Nordisk’s Wegovy pill, which came out in January, hit over 18,000 prescriptions in its second week.

The FDA approved Foundayo on April 1 and shipments began on April 9. Deutsche analysts noted that Lilly’s GLP-1 injections, which currently outsell Novo’s, also had a slower start.

Lilly fell more than 4% after the numbers were released. Novo Nordisk rose more than 5%.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, Robinhood Derivatives, LLC, or Robinhood Money, LLC. Futures and event contracts are offered through Robinhood Derivatives, LLC.